Role of the polypill for secondary prevention in ischaemic heart disease

Uses of polypills for cardiovascular disease and evidence to date

(2017) Mark D Huffman et al.   LANCET

Putting polypills into practice: challenges and lessons learned

(2017) Ruth Webster et al.   LANCET

Utilidad de un policomprimido cardiovascular en el tratamiento de pacientes en prevención secundaria en España: un estudio de coste-efectividad

(2017) Vivencio Barrios et al.   REVISTA ESPANOLA DE CARDIOLOGIA

2016 European Guidelines on cardiovascular disease prevention in clinical practice

(2016) Massimo F. Piepoli et al.   EUROPEAN HEART JOURNAL

Effectiveness of fixed dose combination medication (‘polypills’) compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries

(2016) Ruth Webster et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes

(2016) Sameer Bansilal et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Polypill-based therapy likely to reduce ethnic inequities in use of cardiovascular preventive medications: Findings from a pragmatic randomised controlled trial

(2016) Vanessa Selak et al.   European Journal of Preventive Cardiology

Estimated cardiovascular relative risk reduction from fixed-dose combination pill (polypill) treatment in a wide range of patients with a moderate risk of cardiovascular disease

(2016) Melvin Lafeber et al.   European Journal of Preventive Cardiology

Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK

(2015) V. Becerra et al.   BMJ Open

Polypill: Progress and Challenges to Global Use—Update on the Trials and Policy Implementation

(2015) Ruth Webster et al.   Current Cardiology Reports

Evolution of the Polypill Concept and Ongoing Clinical Trials

(2014) Jose M. Castellano et al.   CANADIAN JOURNAL OF CARDIOLOGY

A Polypill Strategy to Improve Global Secondary Cardiovascular Prevention

(2014) José M. Castellano et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Polypill Strategy to Improve Adherence

(2014) José M. Castellano et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care

(2014) V. Selak et al.   BMJ-British Medical Journal

A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk

(2014) Anushka Patel et al.   European Journal of Preventive Cardiology

Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences

(2013) Rajiv Chowdhury et al.   EUROPEAN HEART JOURNAL

Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD

(2013) Simon Thom   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Adherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 Patients

(2012) Sayed H. Naderi et al.   AMERICAN JOURNAL OF MEDICINE

Medication adherence: A call for action

(2011) Hayden B. Bosworth et al.   AMERICAN HEART JOURNAL

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

(2011) Salim Yusuf et al.   LANCET